136 related articles for article (PubMed ID: 35278135)
21. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence.
Lu DJ; Luu M; Nguyen AT; Scher KS; Clair JM; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2019 Dec; 99():104472. PubMed ID: 31704556
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic pentoxifylline and vitamin E use for dental extractions in irradiated patients with head and neck cancer.
Samani M; Beheshti S; Cheng H; Sproat C; Kwok J; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Mar; 133(3):e63-e71. PubMed ID: 34753695
[TBL] [Abstract][Full Text] [Related]
23. Timing of dental extractions in patients undergoing radiotherapy and the incidence of osteoradionecrosis: a systematic review and meta-analysis.
Beaumont S; Bhatia N; McDowell L; Fua T; McCullough M; Celentano A; Yap T
Br J Oral Maxillofac Surg; 2021 Jun; 59(5):511-523. PubMed ID: 33685773
[TBL] [Abstract][Full Text] [Related]
24. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Ou D; Levy A; Blanchard P; Nguyen F; Garberis I; Casiraghi O; Scoazec JY; Janot F; Temam S; Deutsch E; Tao Y
Oral Oncol; 2016 Aug; 59():50-57. PubMed ID: 27424182
[TBL] [Abstract][Full Text] [Related]
25. Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Willemsen ACH; Degens JHRJ; Baijens LWJ; Dingemans AC; Hoeben A; Hoebers FJP; De Ruysscher DKM; Schols AMWJ
Front Nutr; 2020; 7():600612. PubMed ID: 33324671
[No Abstract] [Full Text] [Related]
26. Development of a local dose-response relationship for osteoradionecrosis within the mandible.
Sijtsema ND; Verduijn GM; Nasserinejad K; van Norden Y; Mast H; van der Lugt A; Hoogeman MS; Petit SF
Radiother Oncol; 2023 Sep; 186():109736. PubMed ID: 37315578
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
Kawai S; Yokota T; Onozawa Y; Hamauchi S; Fukutomi A; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Todaka A; Tsushima T; Yoshida Y; Kito Y; Mori K; Yasui H
BMC Cancer; 2017 Jan; 17(1):59. PubMed ID: 28095814
[TBL] [Abstract][Full Text] [Related]
28. Can the prophylactic use of pentoxifylline and tocopherol before dental extractions prevent osteoradionecrosis? A systematic review.
Paiva GLA; de Campos WG; Rocha AC; Júnior CAL; Migliorati CA; Dos Santos Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jul; 136(1):33-41. PubMed ID: 36882364
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
Burningham K; Moore W; Moon D; Avkshtol V; Day AT; Sumer B; Vo D; Bishop JA; Hughes R; Sher DJ
Oral Oncol; 2021 Dec; 123():105623. PubMed ID: 34801975
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic use of pentoxifylline and tocopherol in patients who require dental extractions after radiotherapy for cancer of the head and neck.
Patel V; Gadiwalla Y; Sassoon I; Sproat C; Kwok J; McGurk M
Br J Oral Maxillofac Surg; 2016 Jun; 54(5):547-50. PubMed ID: 26975577
[TBL] [Abstract][Full Text] [Related]
31. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
32. Dental extractions related to head and neck radiotherapy: ten-year experience of a single institution.
Koga DH; Salvajoli JV; Kowalski LP; Nishimoto IN; Alves FA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):e1-6. PubMed ID: 18329909
[TBL] [Abstract][Full Text] [Related]
33. Dental extractions for preradiation dental clearance and incidence of osteoradionecrosis in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
See Toh YL; Soong YL; Chim YX; Tan LT; Lye WK; Teoh KH
J Investig Clin Dent; 2018 May; 9(2):e12295. PubMed ID: 28862391
[TBL] [Abstract][Full Text] [Related]
34. Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma.
De Felice F; Musio D; Abate G; Moscarelli E; Bulzonetti N; Tombolini V
J Cancer Res Clin Oncol; 2020 Feb; 146(2):477-483. PubMed ID: 31686249
[TBL] [Abstract][Full Text] [Related]
35. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
Waddle MR; Ma DJ; Visscher SL; Borah BJ; May JM; Price KA; Moore EJ; Patel SH; Hinni ML; Chintakuntlawar AV; Garcia JJ; Graner DE; Neben-Wittich MA; Garces YI; Hallemeier CL; Price DL; Kasperbauer JL; Janus JR; Foote RL; Miller RC
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):396-402. PubMed ID: 33359567
[TBL] [Abstract][Full Text] [Related]
36. Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience.
Meccariello G; Bianchi G; Calpona S; Parisi E; Cammaroto G; Iannella G; Sgarzani R; Montevecchi F; De Vito A; Capaccio P; Pelucchi S; Vicini C
Oral Oncol; 2020 Nov; 110():104889. PubMed ID: 32653838
[TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.
Sher DJ; Schwartz DL; Nedzi L; Khan S; Hughes R; Fidler MJ; Koshy M
Oral Oncol; 2016 Mar; 54():58-67. PubMed ID: 26794877
[TBL] [Abstract][Full Text] [Related]
38. Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan.
Kapała A; Surwiłło-Snarska A; Jodkiewicz M; Kawecki A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064057
[TBL] [Abstract][Full Text] [Related]
39. Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.
Watson E; El Maghrabi A; Lee JH; Pu J; Xu W; Joudah S; D'Souza V; Quiñonez C; Mojdami ZD; Huang SH; O'Sullivan B; Ringash J; Kim J; Cho J; Bratman S; Waldron J; Goldstein D; Abdalaty AH; Glogauer M; Hope A
Oral Oncol; 2023 Oct; 145():106527. PubMed ID: 37499325
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
Tang WH; Sun W; Long GX
Medicine (Baltimore); 2020 Sep; 99(36):e21785. PubMed ID: 32899005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
